Discovery of novel and highly potential inhibitors of glycogen synthase kinase 3-beta (GSK-3β) through structure-based pharmacophore modeling, virtual computational screening, docking and in silico ADMET analysis-Reference-Cited by-同舟云学术

Discovery of novel and highly potential inhibitors of glycogen synthase kinase 3-beta (GSK-3β) through structure-based pharmacophore modeling, virtual computational screening, docking and in silico ADMET analysis

Published:2023-07-27 Issue: Volume: Page:1-16
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Benghanem Soumia¹,Mesli Fouzia²,Fatima Zohra Hadjadj Aoul³,Nacereddine Chaida¹,Hadjer Chenaffa¹,Abdellatif Merzoug⁴

Affiliation:

1. Faculty of Medicine, Laboratory of Therapeutic Chemistry, Tlemcen University, Tlemcen, Algeria

2. Faculty of Science, Laboratory of Natural and Bio-Actives Substances, Tlemcen University, Tlemcen, Algeria

3. Faculty of Pharmacy, Laboratory of Therapeutic Chemistry, Benyoucef Benkhadda University, Tlemcen, Algeria

4. Faculty of Technology, Tlemcen University, Tlemcen, Algeria

Funder

Algerian Ministry of Higher Education and Scientific Research

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2238062

Reference55 articles.

1. Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression

2. Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3β inhibitors

3. Design of Glycogen Synthase Kinase-3 Inhibitors: An Overview on Recent Advancements

4. ProTox-II: a webserver for the prediction of toxicity of chemicals

5. Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418